{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T11:52:34Z","timestamp":1792497154128,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd007813.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T00:00:00Z","timestamp":1533772800000}}],"reference-count":165,"publisher":"Wiley","issue":"8","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd007813.pub3","type":"journal-article","created":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T15:11:47Z","timestamp":1533827507000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults"],"prefix":"10.1002","volume":"2018","author":[{"given":"Xavier","family":"Castells","sequence":"first","affiliation":[{"name":"Universitat de Girona; Unit of Clinical Pharmacology, TransLab Research Group, Department of Medical Sciences; Emili Grahit, 77 Girona Catalonia Spain 17071"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00eddia","family":"Blanco-Silvente","sequence":"additional","affiliation":[{"name":"Universitat de Girona; Unit of Clinical Pharmacology, TransLab Research Group, Department of Medical Sciences; Emili Grahit, 77 Girona Catalonia Spain 17071"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Cunill","sequence":"additional","affiliation":[{"name":"Parc Sanitari Sant Joan de D\u00e9u; Parc Sanitari Sant Joan de D\u00e9u - Numancia; Barcelona Catalunya Spain 08735"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,8,9]]},"reference":[{"key":"10.1002\/14651858.CD007813.pub3-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1744-9081-5-34","article-title":"Effect of lisdexamfetamine dimesylate on sleep in adults with attention-deficit\/hyperactivity disorder","volume":"5","author":"Adler","year":"2009","journal-title":"Behavioral and Brain Functions"},{"issue":"9","key":"10.1002\/14651858.CD007813.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.4088\/JCP.v69n0903","article-title":"Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit\/hyperactivity disorder","volume":"69","author":"Adler","year":"2008","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD007813.pub3-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/2050-6511-13-18","article-title":"Efficacy of lisdexamfetamine dimesylate in adults with attention-deficit\/hyperactivity disorder previously treated with amphetamines: analyses from a randomized, double-blind, multicenter, placebo-controlled titration study","volume":"13","author":"Babcock","year":"2012","journal-title":"BMC Pharmacology & Toxicology"},{"issue":"2","key":"10.1002\/14651858.CD007813.pub3-BIB0004|cit4","first-page":"28","article-title":"Lisdexamfetamine dimesylate for the treatment of attention deficit hyperactivity disorder in adults with a history of depression or history of substance use disorder","volume":"8","author":"Kollins","year":"2011","journal-title":"Innovations in Clinical Neuroscience"},{"key":"10.1002\/14651858.CD007813.pub3-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1471-244X-13-39","article-title":"Clinical response and symptomatic remission in short- and long-term trials of lisdexamfetamine dimesylate in adults with attention-deficit\/hyperactivity disorder","volume":"13","author":"Mattingly","year":"2013","journal-title":"BMC Psychiatry"},{"key":"10.1002\/14651858.CD007813.pub3-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/1471-244X-13-253","article-title":"Self-reported quality of life in adults with attention-deficit\/hyperactivity disorder and executive function impairment treated with lisdexamfetamine dimesylate: a randomized, double-blind, multicenter, placebo-controlled, parallel-group study","volume":"13","author":"Adler","year":"2013","journal-title":"BMC Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD007813.pub3-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"694","DOI":"10.4088\/JCP.12m08144","article-title":"Lisdexamfetamine dimesylate in adults with attention-deficit\/hyperactivity disorder who report clinically significant impairment in executive function: results from a randomized, double-blind, placebo-controlled study","volume":"74","author":"Adler","year":"2013","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD007813.pub3-BIB0008|cit8","doi-asserted-by":"crossref","unstructured":"Weisler R Ginsberg L Dirks B Deas P Adeyi B Adler LA Treatment with lisdexamfetamine dimesylate improves self- and informant-rated executive function behaviors and clinician- and informant-rated ADHD symptoms in adults: data from a randomized, double-blind, placebo-controlled study Journal of Attention Disorders 2017 1198 207 10.1177\/1087054713518242","DOI":"10.1177\/1087054713518242"},{"issue":"6","key":"10.1002\/14651858.CD007813.pub3-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.jadohealth.2012.03.005","article-title":"The effects of lisdexamfetamine dimesylate on driving behaviors in young adults with ADHD assessed with the Manchester driving behavior questionnaire","volume":"51","author":"Biederman","year":"2012","journal-title":"Journal of Adolescent Health"},{"issue":"4","key":"10.1002\/14651858.CD007813.pub3-BIB0010|cit10","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.jpsychires.2012.01.007","article-title":"The effects of lisdexamfetamine dimesylate on the driving performance of young adults with ADHD: a randomized, double-blind, placebo-controlled study using a validated driving simulator paradigm","volume":"46","author":"Biederman","year":"2012","journal-title":"Journal of Psychiatric Research"},{"issue":"7","key":"10.1002\/14651858.CD007813.pub3-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"977","DOI":"10.4088\/JCP.11m07430","article-title":"Maintenance of efficacy of lisdexamfetamine dimesylate in adults with attention-deficit\/hyperactivity disorder: randomized withdrawal design","volume":"73","author":"Brams","year":"2012","journal-title":"Journal of Clinical Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD007813.pub3-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1177\/1087054711427299","article-title":"Double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in college students with ADHD","volume":"16","author":"Dupaul","year":"2012","journal-title":"Journal of Attention Disorders"},{"key":"10.1002\/14651858.CD007813.pub3-BIB0013|cit13","unstructured":"Frick G Yan B Adler LA Triple-Bead Mixed Amphetamine Salts (SHP465) in adults with ADHD: results of a phase 3, double-blind, randomized, forced-dose trial Journal of Attention Disorders 10.1177\/1087054717696771"},{"issue":"4","key":"10.1002\/14651858.CD007813.pub3-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1177\/1087054708322986","article-title":"Simulated driving changes in young adults with ADHD receiving mixed amphetamine salts extended release and atomoxetine","volume":"12","author":"Kay","year":"2009","journal-title":"Journal of Attention Disorders"},{"issue":"2","key":"10.1002\/14651858.CD007813.pub3-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1177\/1087054712440320","article-title":"A pilot study of lis-dexamfetamine dimesylate (LDX\/SPD489) to facilitate smoking cessation in nicotine-dependent adults with ADHD","volume":"18","author":"Kollins","year":"2014","journal-title":"Journal of Attention Disorders"},{"issue":"6","key":"10.1002\/14651858.CD007813.pub3-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1001\/jamapsychiatry.2015.41","article-title":"Extended-release mixed amphetamine salts vs placebo for comorbid adult attention-deficit\/hyperactivity disorder and cocaine use disorder: a randomized clinical trial","volume":"72","author":"Levin","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD007813.pub3-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1111\/ajad.12467","article-title":"Mixed-amphetamine salts increase abstinence from marijuana in patients with co-occurring attention-deficit\/hyperactivity disorder and cocaine dependence","volume":"25","author":"Notzon","year":"2016","journal-title":"American Journal on Addictions"},{"issue":"2","key":"10.1002\/14651858.CD007813.pub3-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s40261-013-0156-z","article-title":"Randomized, double-blind, placebo-controlled, crossover study of the effects of lisdexamfetamine dimesylate and mixed amphetamine salts on cognition throughout the day in adults with attention-deficit\/hyperactivity disorder","volume":"34","author":"Martin","year":"2014","journal-title":"Clinical Drug Investigation"},{"issue":"2","key":"10.1002\/14651858.CD007813.pub3-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s40261-013-0156-z","article-title":"Randomized, double-blind, placebo-controlled, crossover study of the effects of lisdexamfetamine dimesylate and mixed amphetamine salts on cognition throughout the day in adults with attention-deficit\/hyperactivity disorder","volume":"34","author":"Martin","year":"2014","journal-title":"Clinical Drug Investigation"},{"issue":"8","key":"10.1002\/14651858.CD007813.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1001\/archpsyc.58.8.775","article-title":"Efficacy of a mixed amphetamine salts compound in adults with attention-deficit\/hyperactivity disorder","volume":"58","author":"Spencer","year":"2001","journal-title":"Archives of General Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD007813.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.4088\/JCP.v69n0911","article-title":"Triple-bead mixed amphetamine salts (SPD465), a novel, enhanced extended-release amphetamine formulation for the treatment of adults with ADHD: a randomized, double-blind, multicenter, placebo-controlled study","volume":"69","author":"Spencer","year":"2008","journal-title":"Journal of Clinical Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD007813.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.4088\/JCP.v69n1112","article-title":"Attention-deficit\/hyperactivity disorder-specific quality of life with triple-bead mixed amphetamine salts (SPD465) in adults: results of a randomized, double-blind, placebo-controlled study","volume":"69","author":"Spencer","year":"2008","journal-title":"Journal of Clinical Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD007813.pub3-BIB0023|cit23","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1089\/cap.2000.10.311","article-title":"Efficacy of modafinil compared to dextroamphetamine for the treatment of attention deficit hyperactivity disorder in adults","volume":"10","author":"Taylor","year":"2000","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD007813.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/00004714-200104000-00015","article-title":"Comparing guanfacine and dextroamphetamine for the treatment of adult attention-deficit\/hyperactivity disorder","volume":"21","author":"Taylor","year":"2001","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD007813.pub3-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1089\/cap.2016.0129","article-title":"Parent-reported improvements in family functioning in a randomized controlled trial of lisdexamfetamine for treatment of parental attention-deficit\/hyperactivity disorder","volume":"27","author":"Babinski","year":"2017","journal-title":"Journal of Child and Adolescent Psychopharmacolgy"},{"issue":"7","key":"10.1002\/14651858.CD007813.pub3-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s40263-014-0165-3","article-title":"Does pharmacological treatment of ADHD in adults enhance parenting performance? Results of a double-blind randomized trial","volume":"28","author":"Waxmonsky","year":"2014","journal-title":"CNS Drugs"},{"issue":"12 Suppl 20","key":"10.1002\/14651858.CD007813.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1017\/S1092852900002406","article-title":"Long-term safety and effectiveness of mixed amphetamine salts extended release in adults with ADHD","volume":"10","author":"Biederman","year":"2005","journal-title":"CNS Spectrums"},{"issue":"12 Suppl 20","key":"10.1002\/14651858.CD007813.pub3-BIB0029|cit28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1017\/S109285290000242X","article-title":"Long-term cardiovascular effects of mixed amphetamine salts extended release in adults with ADHD","volume":"10","author":"Weisler","year":"2005","journal-title":"CNS Spectrums"},{"issue":"8","key":"10.1002\/14651858.CD007813.pub3-BIB0028|cit29","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1017\/S1092852900013687","article-title":"Mixed amphetamine salts extended-release in the treatment of adult ADHD: a randomized, controlled trial","volume":"11","author":"Weisler","year":"2006","journal-title":"CNS Spectrums"},{"issue":"8","key":"10.1002\/14651858.CD007813.pub3-BIB0030|cit30","doi-asserted-by":"publisher","first-page":"685-97","DOI":"10.1007\/s40263-017-0455-7","article-title":"Efficacy and safety of SHP465 mixed amphetamine salts in the treatment of attention-deficit\/hyperactivity disorder in adults: results of a randomized, double-blind, placebo-controlled, forced-dose clinical study","volume":"31","author":"Weisler","year":"2017","journal-title":"CNS Drugs"},{"issue":"4","key":"10.1002\/14651858.CD007813.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"611","DOI":"10.4088\/JCP.v67n0412","article-title":"A randomized double-blind trial of paroxetine and\/or dextroamphetamine and problem-focused therapy for attention-deficit\/hyperactivity disorder in adults","volume":"67","author":"Weiss","year":"2006","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD007813.pub3-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1471-244X-12-30","article-title":"A randomized controlled trial of CBT therapy for adults with ADHD with and without medication","volume":"12","author":"Weiss","year":"2012","journal-title":"BMC Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD007813.pub3-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3810\/pgm.2011.03.2275","article-title":"Effect size of lisdexamfetamine dimesylate in adults with attention-deficit\/hyperactivity disorder","volume":"123","author":"Wigal","year":"2011","journal-title":"Postgraduate Medicine"},{"key":"10.1002\/14651858.CD007813.pub3-BIB0034|cit34","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1744-9081-6-34","article-title":"Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit\/hyperactivity disorder: novel findings using a simulated adult workplace environment design","volume":"6","author":"Wigal","year":"2010","journal-title":"Behavioral and Brain Functions"},{"issue":"5","key":"10.1002\/14651858.CD007813.pub3-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3810\/pgm.2011.09.2461","article-title":"Medication adherence and symptom reduction in adults treated with mixed amphetamine salts in a randomized crossover study","volume":"123","author":"Adler","year":"2011","journal-title":"Postgraduate Medicine"},{"issue":"5","key":"10.1002\/14651858.CD007813.pub3-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3810\/pgm.2014.09.2796","article-title":"Clinical effects of lisdexamfetamine and mixed amphetamine salts immediate release in adult ADHD: results of a crossover design clinical trial","volume":"126","author":"Adler","year":"2014","journal-title":"Postgraduate Medicine"},{"issue":"2","key":"10.1002\/14651858.CD007813.pub3-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1089\/cap.2016.0121","article-title":"Pharmacokinetic and pharmacodynamic properties of lisdexamfetamine in adults with attention-deficit\/hyperactivity disorder","volume":"27","author":"Adler","year":"2017","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"6","key":"10.1002\/14651858.CD007813.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/jama.1972.03210060047012","article-title":"Hyperkinetic adult. Study of the \"paradoxical\" amphetamine response","volume":"222","author":"Arnold","year":"1972","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD007813.pub3-BIB0039|cit39","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1176\/appi.ps.51.2.169","article-title":"Long-acting stimulants for the treatment of attention-deficit disorder in cocaine-dependent adults","volume":"51","author":"Castaneda","year":"2000","journal-title":"Psychiatric Services"},{"issue":"5","key":"10.1002\/14651858.CD007813.pub3-BIB0040|cit40","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/jclp.20122","article-title":"Pharmacotherapy of adult ADHD","volume":"61","author":"Dodson","year":"2005","journal-title":"Journal of Clinical Psychology"},{"issue":"2","key":"10.1002\/14651858.CD007813.pub3-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1017\/S1461145702002845","article-title":"Efficacy of Adderall and methylphenidate in attention deficit hyperactivity disorder: a drug-placebo and drug-drug response curve analysis of a naturalistic study","volume":"5","author":"Faraone","year":"2002","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"12 Suppl 20","key":"10.1002\/14651858.CD007813.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1017\/S1092852900002418","article-title":"An interim analysis of the Quality of Life, Effectiveness, Safety, and Tolerability (QU.E.S.T.) evaluation of mixed amphetamine salts extended release in adults with ADHD","volume":"10","author":"Goodman","year":"2005","journal-title":"CNS Spectrums"},{"issue":"9","key":"10.1002\/14651858.CD007813.pub3-BIB0043|cit43","first-page":"44","article-title":"Comparative efficacy and safety of lisdexamfetamine dimesylate and mixed amphetamine salts extended release in adults with attention-deficit\/hyperactivity disorder","volume":"17","author":"Lasser","year":"2010","journal-title":"Primary Psychiatry"},{"issue":"5-6","key":"10.1002\/14651858.CD007813.pub3-BIB0044|cit44","first-page":"22","article-title":"Attention deficit hyperactivity disorder subtypes and symptom response in adults treated with lisdexamfetamine dimesylate","volume":"9","author":"Mattingly","year":"2012","journal-title":"Innovations in Clinical Neuroscience"},{"issue":"4","key":"10.1002\/14651858.CD007813.pub3-BIB0045|cit45","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1080\/j.1440-1614.1999.00590.x","article-title":"A randomised, double-blind, placebo-controlled trial of dexamphetamine in adults with attention deficit hyperactivity disorder","volume":"33","author":"Paterson","year":"1999","journal-title":"Australian and New Zealand Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD007813.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s11920-009-0064-3","article-title":"Lisdexamfetamine in the treatment of attention-deficit\/hyperactivity disorder in adults","volume":"11","author":"Rostain","year":"2009","journal-title":"Current Psychiatry Reports"},{"issue":"2","key":"10.1002\/14651858.CD007813.pub3-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.psc.2003.12.002","article-title":"Stimulant treatment of adult attention-deficit\/hyperactivity disorder","volume":"27","author":"Spencer","year":"2004","journal-title":"Psychiatric Clinics of North America"},{"issue":"10","key":"10.1002\/14651858.CD007813.pub3-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.4088\/JCP.10m05979pur","article-title":"Prediction of placebo response in 2 clinical trials of lisdexamfetamine dimesylate for the treatment of ADHD","volume":"72","author":"Waxmonsky","year":"2011","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD007813.pub3-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/NDT.S47087","article-title":"Analysis of individual items on the attention-deficit\/hyperactivity disorder symptom rating scale in children and adults: the effects of age and sex in pivotal trials of lisdexamfetamine dimesylate","volume":"10","author":"Weisler","year":"2014","journal-title":"Neuropsychiatric Disease and Treatment"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD007813.pub3-BIB0050|cit50","first-page":"S82","article-title":"Sleep and emotional reactivity to extended release dexmethylphenidate versus mixed amphetamine salts: a double-blind, placebo controlled study","volume":"19","author":"Wiebe","year":"2010","journal-title":"European Child & Adolescent Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD007813.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"253","DOI":"10.4088\/JCP.v66n0215","article-title":"Blood pressure changes associated with medication treatment of adults with attention-deficit\/hyperactivity disorder","volume":"66","author":"Wilens","year":"2005","journal-title":"Journal of Clinical Psychiatry"},{"issue":"13","key":"10.1002\/14651858.CD007813.pub3-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1017\/S0033291715000756","article-title":"Cognitive-behavioural therapy in medication-treated adults with attention-deficit\/hyperactivity disorder and co-morbid psychopathology: a randomized controlled trial using multi-level analysis","volume":"45","author":"Young","year":"2015","journal-title":"Psychological Medicine"},{"key":"10.1002\/14651858.CD007813.pub3-BIB0053|cit53","unstructured":"NCT00202605 Safety and efficacy of SPD465 in adults with ADHD clinicaltrials.gov\/ct2\/show\/NCT00202605"},{"key":"10.1002\/14651858.CD007813.pub3-BIB0054|cit54","unstructured":"NCT00514202 Pilot study examining effect for dextroamphetamine to treat cocaine dependence plus attention-deficit hyperactivity disorder clinicaltrials.gov\/ct2\/show\/NCT00514202"},{"key":"10.1002\/14651858.CD007813.pub3-BIB0055|cit55","unstructured":"NCT00928148 The safety and efficacy of SPD465 in adults with attention deficit hyperactivity disorder (ADHD) clinicaltrials.gov\/ct2\/show\/NCT00928148"},{"key":"10.1002\/14651858.CD007813.pub3-BIB0056|cit56","unstructured":"NCT01863459 Lisdexamfetamine dimesylate in the treatment of adult ADHD with anxiety disorder comorbidity clinicaltrials.gov\/ct2\/show\/NCT01863459"},{"key":"10.1002\/14651858.CD007813.pub3-BIB0057|cit57","unstructured":"NCT02635035 Shire SCT: lisdexamfetamine treatment for ADHD and SCT clinicaltrials.gov\/ct2\/show\/NCT02635035"},{"key":"10.1002\/14651858.CD007813.pub3-BIB0058|cit58","unstructured":"NCT02803229 Treatment of cannabis use disorder among adults with comorbid attention-deficit\/hyperactivity disorder (MJ-ADHD) clinicaltrials.gov\/ct2\/show\/NCT02803229"},{"key":"10.1002\/14651858.CD007813.pub3-BIB0059|cit59","unstructured":"NCT03153488 Attention deficit hyperactivity disorder (ADHD) prediction of treatment response Clinicaltrials.gov\/ct2\/show\/NCT03153488"},{"issue":"12","key":"10.1002\/14651858.CD007813.pub3-BIB0060|cit60","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.4088\/JCP.09m05335pur","article-title":"Short-term effects of lisdexamfetamine dimesylate on cardiovascular parameters in a 4-week clinical trial in adults with attention-deficit\/hyperactivity disorder","volume":"70","author":"Adler","year":"2009","journal-title":"Journal of Clinical Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD007813.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1038\/sj.npp.1301164","article-title":"Stimulants: therapeutic actions in ADHD","volume":"31","author":"Arnsten","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD007813.pub3-BIB0062|cit62","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"5","key":"10.1002\/14651858.CD007813.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1017\/S1355617702801345","article-title":"Driving in young adults with attention deficit hyperactivity disorder: knowledge, performance, adverse outcomes, and the role of executive functioning","volume":"8","author":"Barkley","year":"2002","journal-title":"Journal of the International Neuropsychology Society"},{"issue":"4","key":"10.1002\/14651858.CD007813.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1001\/jama.289.4.454","article-title":"Scope and impact of financial conflicts of interest in biomedical research: a systematic review","volume":"289","author":"Bekelman","year":"2003","journal-title":"JAMA"},{"issue":"12","key":"10.1002\/14651858.CD007813.pub3-BIB0065|cit65","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1176\/ajp.150.12.1792","article-title":"Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder","volume":"150","author":"Biederman","year":"1993","journal-title":"American Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD007813.pub3-BIB0066|cit66","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1176\/appi.ajp.157.5.816","article-title":"Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type","volume":"157","author":"Biederman","year":"2000","journal-title":"American Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD007813.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"524","DOI":"10.4088\/JCP.v67n0403","article-title":"Functional impairments in adults with self-reports of diagnosed ADHD: a controlled study of 1001 adults in the community","volume":"67","author":"Biederman","year":"2006","journal-title":"Journal of Clinical Psychiatry"},{"issue":"1-2","key":"10.1002\/14651858.CD007813.pub3-BIB0068|cit68","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1155\/NP.2004.77","article-title":"Experimental investigations on dopamine transmission can provide clues on the mechanism of the therapeutic effect of amphetamine and methylphenidate in ADHD","volume":"11","author":"Carboni","year":"2004","journal-title":"Neural Plasticity"},{"issue":"3","key":"10.1002\/14651858.CD007813.pub3-BIB0069|cit69","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.tics.2006.01.011","article-title":"Characterizing cognition in ADHD: beyond executive dysfunction","volume":"10","author":"Castellanos","year":"2006","journal-title":"Trends in Cognitive Sciences"},{"key":"10.1002\/14651858.CD007813.pub3-BIB0070|cit70","unstructured":"Castells X Request of data [personal communication] Email to: Shire"},{"issue":"2","key":"10.1002\/14651858.CD007813.pub3-BIB0071|cit71","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2165\/11539440-000000000-00000","article-title":"Efficacy of methylphenidate for adults with attention-deficit hyperactivity disorder: a meta-regression analysis","volume":"25","author":"Castells","year":"2011","journal-title":"CNS Drugs"},{"issue":"3","key":"10.1002\/14651858.CD007813.pub3-BIB0072|cit72","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s00228-012-1390-7","article-title":"Treatment discontinuation with methylphenidate in adults with attention deficit hyperactivity disorder: a meta-analysis of randomized clinical trials","volume":"69","author":"Castells","year":"2013","journal-title":"European Journal of Clininical Pharmacology"},{"issue":"9","key":"10.1002\/14651858.CD007813.pub3-BIB0073|cit73","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007380.pub4","article-title":"Psychostimulant drugs for cocaine dependence","author":"Castells","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD007813.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s00787-016-0831-8","article-title":"Predictors of persistence of ADHD into adulthood: a systematic review of the literature and meta-analysis","volume":"25","author":"Caye","year":"2016","journal-title":"European Child & Adolescent Psychiatry"},{"issue":"10","key":"10.1002\/14651858.CD007813.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.biopsych.2008.11.016","article-title":"Amphetamine-induced place preference in humans","volume":"65","author":"Childs","year":"2009","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD007813.pub3-BIB0076|cit76","volume-title":"Statistical Power Analysis for Behavioural Sciences","author":"Cohen","year":"1988"},{"key":"10.1002\/14651858.CD007813.pub3-BIB0077|cit77","volume-title":"Conners\u2019 Adult ADHD Rating Scales (CAARS): Technical Manual","author":"Conners","year":"1999"},{"issue":"2","key":"10.1002\/14651858.CD007813.pub3-BIB0078|cit78","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s12402-012-0097-z","article-title":"Is emotional dysregulation part of the psychopathology of ADHD in adults?","volume":"5","author":"Corbisiero","year":"2013","journal-title":"Attention Deficit Hyperactivity Disorders"},{"key":"10.1002\/14651858.CD007813.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/pds.3473","article-title":"Atomoxetine for attention deficit hyperactivity disorder in the adulthood: a meta-analysis and meta-regression","volume":"22","author":"Cunill","year":"2013","journal-title":"Pharmacoepidemiology and Drug Safety"},{"key":"10.1002\/14651858.CD007813.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/0269881114544777","article-title":"Pharmacological treatment of attention deficit hyperactivity disorder with co-morbid drug dependence","volume":"29","author":"Cunill","year":"2015","journal-title":"Journal of Psychopharmacology"},{"key":"10.1002\/14651858.CD007813.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00213-015-4099-3","article-title":"Efficacy, safety and variability in pharmacotherapy for adults with attention deficit hyperactivity disorder: a meta-analysis and meta-regression in over 9000 patients","volume":"233","author":"Cunill","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"issue":"9983","key":"10.1002\/14651858.CD007813.pub3-BIB0082|cit82","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1016\/S0140-6736(14)61684-6","article-title":"Mortality in children, adolescents, and adults with attention deficit hyperactivity disorder: a nationwide cohort study","volume":"385","author":"Dalsgaard","year":"2015","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD007813.pub3-BIB0083|cit83","unstructured":"Deeks JJ Higgins JPT Altman DG editor(s) Chapter 9. Analysing data and undertaking meta-analyses. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017). Cochrane, 2017 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD007813.pub3-BIB0084|cit84","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders: Fifth Edition (DSM-5)","author":"American Psychiatric Association (APA)","year":"2013"},{"key":"10.1002\/14651858.CD007813.pub3-BIB0085|cit85","volume-title":"Diagnostic and Statistical Manual of Mental Disorders: Third Edition (DSM-III)","author":"American Psychiatric Association (APA)","year":"1980"},{"key":"10.1002\/14651858.CD007813.pub3-BIB0086|cit86","volume-title":"Diagnostic and Statistical Manual of Mental Disorders: Third Edition, Revised (DSM-III-R)","author":"American Psychiatric Association (APA)","year":"1987"},{"key":"10.1002\/14651858.CD007813.pub3-BIB0087|cit87","volume-title":"Diagnostic and Statistical Manual of Mental Disorders: Fourth Edition (DSM-IV)","author":"American Psychiatric Association (APA)","year":"1994"},{"key":"10.1002\/14651858.CD007813.pub3-BIB0088|cit88","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890423349","volume-title":"Diagnostic and Statistical Manual of Mental Disorders: Fourth Edition, Text Revision (DSM-IV-TR)","author":"American Psychiatric Association (APA)","year":"2000"},{"key":"10.1002\/14651858.CD007813.pub3-BIB0089|cit89","volume-title":"ADHD Rating Scale-IV: Checklists, Norms and Clinical Interpretation","author":"DuPaul","year":"1998"},{"issue":"7109","key":"10.1002\/14651858.CD007813.pub3-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD007813.pub3-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"5","key":"10.1002\/14651858.CD007813.pub3-BIB0092|cit92","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s40261-015-0354-y","article-title":"Lisdexamfetamine dimesylate: prodrug delivery, amphetamine exposure and duration of efficacy","volume":"36","author":"Ermer","year":"2016","journal-title":"Clinical Drug Investigation"},{"issue":"1","key":"10.1002\/14651858.CD007813.pub3-BIB0093|cit93","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/01.jcp.0000108984.11879.95","article-title":"Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit\/hyperactivity disorder","volume":"24","author":"Faraone","year":"2004","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD007813.pub3-BIB0094|cit94","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1017\/S003329170500471X","article-title":"The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies","volume":"36","author":"Faraone","year":"2006","journal-title":"Psychological Medicine"},{"key":"10.1002\/14651858.CD007813.pub3-BIB0095|cit95","unstructured":"Dexedrine\u00ae (dextroamphetamine sulfate): Spansule\u00ae sustained-release capsules and tablets www.accessdata.fda.gov\/drugsatfda_docs\/label\/2007\/017078s042lbl.pdf"},{"key":"10.1002\/14651858.CD007813.pub3-BIB0096|cit96","unstructured":"Adderall\u00ae www.accessdata.fda.gov\/drugsatfda_docs\/label\/2015\/011522s041lbl.pdf"},{"key":"10.1002\/14651858.CD007813.pub3-BIB0097|cit97","doi-asserted-by":"crossref","unstructured":"Highlights of prescribing information: Vyvanse\u00ae (lisdexamfetamine dimesylate) capsules, for oral use, CII Initial U.S. Approval: 2007 www.accessdata.fda.gov\/drugsatfda_docs\/label\/2015\/021977s039lbl.pdf","DOI":"10.3833\/pdr.v2007i82.356"},{"key":"10.1002\/14651858.CD007813.pub3-BIB0098|cit98","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1146\/annurev.pharmtox.47.120505.105140","article-title":"New insights into the mechanism of action of amphetamines","volume":"47","author":"Fleckenstein","year":"2007","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"10.1002\/14651858.CD007813.pub3-BIB0099|cit99","first-page":"134","article-title":"Psychostimulants actions on dopamine and limbic system function: relevance to the pathophysiology and treatment of ADHD","volume-title":"Stimulant Drugs and ADHD: Basic and Clinical Neuroscience","author":"Grace","year":"2001"},{"key":"10.1002\/14651858.CD007813.pub3-BIB0100|cit100","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT 2015"},{"key":"10.1002\/14651858.CD007813.pub3-BIB0101|cit101","volume-title":"ECDEU Assessment Manual for Psychopharmacology, Revised","author":"Guy","year":"1976"},{"issue":"4","key":"10.1002\/14651858.CD007813.pub3-BIB0102|cit102","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction - GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD007813.pub3-BIB0103|cit103","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jclinepi.2010.07.017","article-title":"GRADE guidelines: 4. Rating the quality of evidence - study limitations (risk of bias)","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD007813.pub3-BIB0104|cit104","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.jclinepi.2011.01.012","article-title":"GRADE guidelines 6. Rating the quality of evidence - imprecision","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD007813.pub3-BIB0105|cit105","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.jclinepi.2011.03.017","article-title":"GRADE guidelines: 7. Rating the quality of evidence - inconsistency","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD007813.pub3-BIB0106|cit106","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/j.jclinepi.2011.04.014","article-title":"GRADE guidelines: 8. Rating the quality of evidence - indirectness","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD007813.pub3-BIB0107|cit107","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jclinepi.2012.01.006","article-title":"GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD007813.pub3-BIB0108|cit108","volume-title":"Goodman & Gilman's The Pharmacological Basis of Therapeutics","author":"Hardman","year":"2001"},{"issue":"6","key":"10.1002\/14651858.CD007813.pub3-BIB0109|cit109","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1177\/0269881113482532","article-title":"Amphetamine, past and present - a pharmacological and clinical perspective","volume":"27","author":"Heal","year":"2013","journal-title":"Journal of Psychopharmacology"},{"key":"10.1002\/14651858.CD007813.pub3-BIB0110|cit110","unstructured":"Higgins JPT Deeks JJ editor(s) Chapter 7. Selecting studies and collecting data. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD007813.pub3-BIB0111|cit111","unstructured":"Higgins JP Green S editor(s) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD007813.pub3-BIB0112|cit112","article-title":"Standards for the conduct of new Cochrane Intervention reviews","volume-title":"Methodological Expectations of Cochrane Intervention Reviews","author":"Higgins","year":"2016"},{"key":"10.1002\/14651858.CD007813.pub3-BIB0113|cit113","unstructured":"Higgins JPT Altman DG Sterne JAC editor(s) Chapter 8. Assessing risk of bias in included studies. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017). Cochrane, 2017 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD007813.pub3-BIB0114|cit114","unstructured":"Higgins JPT Altman DG Sterne JAC editor(s) Chapter 9.5.2. Indetifyin and measuring heterogeneity. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017). Cochrane, 2017 Available from www.training.cochrane.org\/handbook"},{"issue":"9","key":"10.1002\/14651858.CD007813.pub3-BIB0115|cit115","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1176\/ajp.153.9.1143","article-title":"Age-dependent decline of attention deficit hyperactivity disorder","volume":"153","author":"Hill","year":"1996","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD007813.pub3-BIB0116|cit116","volume-title":"The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic guidelines","author":"World Health Organization (WHO)","year":"1992"},{"issue":"10","key":"10.1002\/14651858.CD007813.pub3-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.2165\/00003495-200565100-00006","article-title":"Pharmacotherapy for obesity","volume":"65","author":"Ioannides-Demos","year":"2005","journal-title":"Drugs"},{"issue":"3","key":"10.1002\/14651858.CD007813.pub3-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/BF00433062","article-title":"Drug preference and mood in humans: d-amphetamine","volume":"71","author":"Johanson","year":"1980","journal-title":"Psychopharmacology"},{"issue":"5","key":"10.1002\/14651858.CD007813.pub3-BIB0119|cit119","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1176\/ajp.155.5.646","article-title":"12-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode","volume":"155","author":"Keck","year":"1998","journal-title":"American Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD007813.pub3-BIB0120|cit120","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1176\/ajp.2006.163.4.716","article-title":"The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication","volume":"163","author":"Kessler","year":"2006","journal-title":"American Journal of Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD007813.pub3-BIB0121|cit121","doi-asserted-by":"publisher","first-page":"1168-78","DOI":"10.1001\/archgenpsychiatry.2010.146","article-title":"Structure and diagnosis of adult attention-deficit\/hyperactivity disorder: analysis of expanded symptom criteria from the Adult ADHD Clinical Diagnosis Scale","volume":"67","author":"Kessler","year":"2010","journal-title":"Archives of General Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD007813.pub3-BIB0122|cit122","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1177\/0269881108092338","article-title":"Limits of meta-analysis: methylphenidate in the treatment of adult attention-deficit hyperactivity disorder","volume":"23","author":"Koesters","year":"2009","journal-title":"Journal of Psychopharmacology"},{"issue":"8","key":"10.1002\/14651858.CD007813.pub3-BIB0123|cit123","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1503\/cmaj.051145","article-title":"Inconclusive evidence puts Adderall back on the market","volume":"173","author":"Kondro","year":"2005","journal-title":"Canadian Medical Association Journal"},{"key":"10.1002\/14651858.CD007813.pub3-BIB0124|cit124","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/1471-244X-10-67","article-title":"European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD","volume":"10","author":"Kooij","year":"2010","journal-title":"BMC Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD007813.pub3-BIB0125|cit125","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.biopsych.2008.10.005","article-title":"Childhood predictors of adult ADHD: results from the WHO World Mental Health (WMH) Survey Initiative","volume":"65","author":"Lara","year":"2009","journal-title":"Biological Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD007813.pub3-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"300","DOI":"10.4088\/JCP.v59n0605","article-title":"Methylphenidate treatment for cocaine abusers with attention-deficit hyperactivity disorder: a pilot study","volume":"59","author":"Levin","year":"1998","journal-title":"Journal of Clinical Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD007813.pub3-BIB0127|cit127","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.MR000033.pub3","article-title":"Industry sponsorship and research outcome","author":"Lundh","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD007813.pub3-BIB0128|cit128","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.appet.2003.11.003","article-title":"Wake-promoting agents with different mechanisms of action: comparison of effects of modafinil and amphetamine on food intake and cardiovascular activity","volume":"42","author":"Makris","year":"2004","journal-title":"Appetite"},{"issue":"2","key":"10.1002\/14651858.CD007813.pub3-BIB0129|cit129","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1037\/1064-1297.15.2.123","article-title":"Behavioral and subjective effects of d-amphetamine and modafinil in healthy adults","volume":"15","author":"Makris","year":"2007","journal-title":"Experimental and Clinical Psychopharmacology"},{"issue":"8","key":"10.1002\/14651858.CD007813.pub3-BIB0130|cit130","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1089\/cap.2017.0071","article-title":"The clinical pharmacokinetics of amphetamines utilized in the treatment of attention-deficit\/hyperactivity disorder","volume":"27","author":"Markowitz","year":"2017","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"10","key":"10.1002\/14651858.CD007813.pub3-BIB0131|cit131","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.biopsych.2007.11.008","article-title":"A randomized, placebo-controlled trial of three fixed dosages of prolonged-release OROS methylphenidate in adults with attention-deficit\/hyperactivity disorder","volume":"63","author":"Medori","year":"2008","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD007813.pub3-BIB0132|cit132","unstructured":"Medicines and Healthcare Products Regulatory Agency Public Assessment Report. Decentralised Procedure. Elvanse 30 mg, 50 mg and 70 mg capsules, hard: lisdexamfetamine dimesylate, UK\/H\/3326\/001-03\/DC, UK licence no: PL 08081\/0050-2. Shire Pharmaceuticals Contracts Limited www.mhra.gov.uk\/home\/groups\/par\/documents\/websiteresources\/con261790.pdf"},{"issue":"7","key":"10.1002\/14651858.CD007813.pub3-BIB0133|cit133","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Medicine"},{"issue":"4","key":"10.1002\/14651858.CD007813.pub3-BIB0134|cit134","first-page":"762-9","article-title":"National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: changes in effectiveness and growth after the end of treatment","volume":"113","author":"MTA Cooperative Group","year":"2004","journal-title":"Pediatrics"},{"issue":"Suppl 13","key":"10.1002\/14651858.CD007813.pub3-BIB0135|cit135","first-page":"9","article-title":"Narcolepsy: pathophysiology and pharmacology","volume":"68","author":"Nishino","year":"2007","journal-title":"Journal of Clinical Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD007813.pub3-BIB0136|cit136","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006997.pub2","article-title":"Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents","author":"Otasowie","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD007813.pub3-BIB0137|cit137","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00213-007-0996-4","article-title":"Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysis","volume":"197","author":"Peterson","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD007813.pub3-BIB0138|cit138","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.neuropharm.2014.04.002","article-title":"Psychostimulant addiction treatment","volume":"87","author":"Phillips","year":"2014","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1002\/14651858.CD007813.pub3-BIB0139|cit139","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009996.pub2","article-title":"Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents","author":"Punja","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD007813.pub3-BIB0140|cit140","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1586\/ern.12.109","article-title":"Emotional dysregulation in adult ADHD: what is the empirical evidence?","volume":"12","author":"Retz","year":"2012","journal-title":"Expert Review of Neurotherapeutics"},{"key":"10.1002\/14651858.CD007813.pub3-BIB0141|cit141","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"issue":"2","key":"10.1002\/14651858.CD007813.pub3-BIB0142|cit142","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.acn.2004.07.005","article-title":"Attention deficit hyperactivity disorder: manifestation in adulthood","volume":"20","author":"Riccio","year":"2005","journal-title":"Archives of Clinical Neuropsychology"},{"key":"10.1002\/14651858.CD007813.pub3-BIB0143|cit143","doi-asserted-by":"crossref","unstructured":"Riera M Castells X Tobias A Cunill R Blanco L Capell\u00e0 D Discontinuation of pharmacological treatment of children and adolescents with attention deficit hyperactivity disorder: meta-analysis of 63 studies enrolling 11,788 patients Psychopharmacology 2017 2657 71 10.1007\/s00213-017-4662-1","DOI":"10.1007\/s00213-017-4662-1"},{"issue":"6","key":"10.1002\/14651858.CD007813.pub3-BIB0144|cit144","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1177\/1087054715605915","article-title":"Recent trends in stimulant usage","volume":"20","author":"Safer","year":"2016","journal-title":"Journal of Attention Disorders"},{"issue":"15","key":"10.1002\/14651858.CD007813.pub3-BIB0145|cit145","doi-asserted-by":"publisher","first-page":"1525-38","DOI":"10.1056\/NEJMoa061240","article-title":"Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease","volume":"355","author":"Schneider","year":"2006","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD007813.pub3-BIB0146|cit146","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.acn.2005.04.005","article-title":"Neuropsychological performance in adult attention-deficit hyperactivity disorder: meta-analysis of empirical data","volume":"20","author":"Schoechlin","year":"2005","journal-title":"Archives of Clinical Neuropsychology"},{"issue":"5","key":"10.1002\/14651858.CD007813.pub3-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD007813.pub3-BIB0148|cit148","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1080\/09595230220139082","article-title":"Substitution therapy for amphetamine users","volume":"21","author":"Shearer","year":"2002","journal-title":"Drug and Alcohol Review"},{"issue":"3","key":"10.1002\/14651858.CD007813.pub3-BIB0149|cit149","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1192\/bjp.bp.107.048827","article-title":"Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis","volume":"194","author":"Simon","year":"2009","journal-title":"British Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD007813.pub3-BIB0150|cit150","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.chc.2007.11.008","article-title":"Executive dysfunction and delay aversion in attention deficit hyperactivity disorder: nosologic and diagnostic implications","volume":"17","author":"Sonuga-Barke","year":"2008","journal-title":"Child and Adolescent Psychiatric Clinics of North America"},{"issue":"12","key":"10.1002\/14651858.CD007813.pub3-BIB0151|cit151","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.biopsych.2006.07.032","article-title":"Efficacy and safety of dexmethylphenidate extended-release capsules in adults with attention-deficit\/hyperactivity disorder","volume":"61","author":"Spencer","year":"2007","journal-title":"Biological Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD007813.pub3-BIB0152|cit152","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009885.pub2","article-title":"Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)","author":"Storeb\u00f8","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD007813.pub3-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/oxfordjournals.schbul.a006986","article-title":"The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development","volume":"29","author":"Stroup","year":"2003","journal-title":"Schizophrenia Bulletin"},{"issue":"6","key":"10.1002\/14651858.CD007813.pub3-BIB0154|cit154","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.pneurobio.2005.04.003","article-title":"Mechanisms of neurotransmitter release by amphetamines: a review","volume":"75","author":"Sulzer","year":"2005","journal-title":"Progress in Neurobiolology"},{"issue":"1","key":"10.1002\/14651858.CD007813.pub3-BIB0155|cit155","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11065-007-9019-9","article-title":"Etiologic subtypes of attention-deficit\/hyperactivity disorder: brain imaging, molecular genetic and environmental factors and the dopamine hypothesis","volume":"17","author":"Swanson","year":"2007","journal-title":"Neuropsychology Review"},{"issue":"10024","key":"10.1002\/14651858.CD007813.pub3-BIB0156|cit156","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/S0140-6736(15)00238-X","article-title":"Attention deficit hyperactivity disorder","volume":"387","author":"Thapar","year":"2016","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD007813.pub3-BIB0157|cit157","doi-asserted-by":"publisher","first-page":"e994","DOI":"10.1542\/peds.2014-3482","article-title":"Prevalence of attention-deficit\/hyperactivity disorder: a systematic review and meta-analysis","volume":"135","author":"Thomas","year":"2015","journal-title":"Pediatrics"},{"issue":"1-2","key":"10.1002\/14651858.CD007813.pub3-BIB0158|cit158","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.drugalcdep.2011.12.007","article-title":"Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis","volume":"122","author":"Emmerik-Van Oortmerssen","year":"2012","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1002\/14651858.CD007813.pub3-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00008877-199905000-00004","article-title":"Subjective and behavioral effects of repeated d-amphetamine in humans","volume":"10","author":"Wachtel","year":"1999","journal-title":"Behavioral Pharmacology"},{"issue":"5","key":"10.1002\/14651858.CD007813.pub3-BIB0160|cit160","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1037\/pha0000093","article-title":"Prescription stimulant medication misuse: where are we and where do we go from here?","volume":"24","author":"Weyandt","year":"2016","journal-title":"Experimental and Clinical Psychopharmacology"},{"issue":"22","key":"10.1002\/14651858.CD007813.pub3-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.2165\/00003495-200363220-00002","article-title":"Drug therapy for adults with attention-deficit hyperactivity disorder","volume":"63","author":"Wilens","year":"2003","journal-title":"Drugs"},{"issue":"3","key":"10.1002\/14651858.CD007813.pub3-BIB0162|cit162","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1007\/s13311-012-0135-8","article-title":"The prevalence of DSM-IV attention-deficit\/hyperactivity disorder: a meta-analytic review","volume":"9","author":"Willcutt","year":"2012","journal-title":"Neurotherapeutics"},{"issue":"3","key":"10.1002\/14651858.CD007813.pub3-BIB0163|cit163","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/j.1469-7610.2004.00350.x","article-title":"The adolescent outcome of hyperactive girls: self-report of psychosocial\u00a0 status","volume":"46","author":"Young","year":"2005","journal-title":"Journal of Child Psychology and Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD007813.pub3-BIB0164|cit164","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007813","article-title":"Amfetamines for Attention Deficit Hyperactivity Disorder (ADHD) in adults","author":"Castells","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD007813.pub3-BIB0165|cit165","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007813.pub2","article-title":"Amphetamines for Attention Deficit Hyperactivity Disorder (ADHD) in adults","author":"Castells","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD007813.pub3\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T08:41:52Z","timestamp":1672044112000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD007813.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Developmental, Psychosocial and Learning Problems Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,8,9]]},"references-count":165,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,8]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007813.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,9]]}}}